Trial intelligence / Profile preview

Remimazolam versus propofol for general anesthesia in adult cardiac surgery

NL-OMON42664Phase 3Active, not recruiting

Sponsor
PAION AG
Start
Aug 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial comparing Remimazolam with Propofol (2 arms). Primary endpoint: Successful sedation. Started Aug 2015; status: active, not recruiting.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on NL-OMON42664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON42664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call